(19)
(11) EP 2 847 209 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
07.10.2020 Bulletin 2020/41

(45) Mention of the grant of the patent:
05.08.2020 Bulletin 2020/32

(21) Application number: 13722023.2

(22) Date of filing: 09.05.2013
(51) International Patent Classification (IPC): 
C07K 7/08(2006.01)
A61K 39/35(2006.01)
 A61K 45/06(2006.01)
A61K 39/00(2006.01)
(86) International application number:
PCT/GB2013/051201
(87) International publication number:
WO 2013/167897 (14.11.2013 Gazette 2013/46)

(54)

HYDROCHLORIDE SALT OF PEPTIDE AND ITS USE IN COMBINATION WITH OTHER PEPTIDES FOR IMMUNOTHERAPY

CHLORHYDRATSALZ EINES PEPTIDES UND DEREN VERWENDUNG IN ZUSAMMENHANG MIT ANDEREN PEPTIDEN FÜR IMMUNOTHERAPIE

SEL CHLORHYDRIQUE D'UN PEPTIDE ET SON USAGE EN IMMUNOTHÉRAPIE EN COMBINAISON AVEC D'AUTRES PEPTIDES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.05.2012 GB 201208293

(43) Date of publication of application:
18.03.2015 Bulletin 2015/12

(73) Proprietor: Adiga Life Sciences Limited
Oxford OX4 4GP (GB)

(72) Inventors:
  • LAIDLER, Paul
    Oxford Oxfordshire OX4 4GA (GB)
  • FARKAS, Imre
    CH-4416 Bubendorf (CH)

(74) Representative: J A Kemp LLP 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)


(56) References cited: : 
WO-A1-2008/145998
WO-A2-2009/022155
 WO-A2-03/047618
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).